Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn
On the reasons for the acquisition, Sun Pharma said it is a strategic investment to support the development of innovative
Continue readingThe Number One Finance & Business Blog!
On the reasons for the acquisition, Sun Pharma said it is a strategic investment to support the development of innovative
Continue reading